首页> 外文期刊>Hemijska industrija >In vitro dissolution profile study of mucolytic drug ambroxol hydrochloride from solid oral dosage form by UHPLC-MS/MS
【24h】

In vitro dissolution profile study of mucolytic drug ambroxol hydrochloride from solid oral dosage form by UHPLC-MS/MS

机译:通过UHPLC-MS / MS研究固体溶剂中黏液溶解药物盐酸氨溴索的体外溶出特性

获取原文
       

摘要

In this paper a simplified dissolution test was performed for the release of ambroxol from tablets according to the European Pharmacopoeia. In vitro, three different dissolution media; 0.1 M HCl pH 1.2, acetate buffer (ABS) pH 4.5 and phosphate buffer (PBS) pH 6.8 were used for the simulation of the gastrointestinal conditions at temperature of 37.0±0.5°C. The drug release was evaluated by a new ultra - high performance liquid chromatography (UHPLC) - tandem mass spectrometry (MS/MS) method. The method was validated to meet requirements as per ICH guidelines which include linearity, specificity, precision, accuracy and robustness. The corresponding dissolution profiles showed more than 80% drug release within 30 minutes without significant differences. Further, the developed and validated UHPLC-MS/MS method could find a useful application in the process of production, quality control and bioavailability/bioequivalence studies of new pharmaceutical formulations of drugs in order to achieve a safe therapeutic efficacy. [Projekat Ministarstva nauke Republike Srbije, br. 175045]
机译:本文根据欧洲药典对从片剂中释放的氨溴索进行了简化的溶出度测试。在体外,三种不同的溶出介质; 0.1 M HCl pH 1.2,乙酸盐缓冲液(ABS)pH 4.5和磷酸盐缓冲液(PBS)pH 6.8用于模拟37.0±0.5°C温度下的胃肠道条件。通过新型超高效液相色谱(UHPLC)-串联质谱(MS / MS)方法评估药物释放。该方法经验证符合ICH指南的要求,包括线性,特异性,精密度,准确性和鲁棒性。相应的溶出曲线显示30分钟内药物释放超过80%,无明显差异。此外,已开发和验证的UHPLC-MS / MS方法可在新药物制剂的生产,质量控制和生物利用度/生物等效性研究过程中找到有用的应用,以实现安全的治疗功效。 [Projekat Ministarstva nauke Republike Srbije,br。 175045]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号